RAVGEN, INC. — Form D/A
RAVGEN, INC. of COLUMBIA, MD, a company, filed a Form D amendment with the SEC on 2021-07-27. The offering totals $3.5M, of which $2.1M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2021-07-27
- Form: D/A
- Accession: 0001140834-21-000006
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $3.5M
- Amount sold: $2.1M
- Remaining: $1.4M
- Minimum investment: $100K
- Investors: 6
- Date of first sale: 2021-05-20
- Security types: debt
- Revenue range: Decline to Disclose
- SEC file number: 021-401584
Issuer
- Name: RAVGEN, INC.
- CIK: 0001140834
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Address: 9241 RUMSEY ROAD, COLUMBIA, MD, 21045
- Phone: 4107152111
Officers, directors & promoters (14)
| Name | Role | Location |
|---|
| Kamlesh Dhallan | Director | Columbia, MD |
| Philip Bayliss | Director | Columbia, MD |
| Edward Mottern | Director | Columbia, MD |
| Narender Dhallan | Director | Columbia, MD |
| Ravinder Dhallan | Director | Columbia, MD |
| Ravinder Dhallan | Executive Officer | Columbia, MD |
| Ravinder Dhallan | Promoter | Columbia, MD |
| Ravinder S Dhallan | Director | Bethesda, MD |
| Ravinder S Dhallan | Executive Officer | Bethesda, MD |
| Ravinder S Dhallan | Promoter | Bethesda, MD |
| Edward S Mottern | Director | White Hall, MD |
| Kamlesh S Miller | Director | Bethesda, MD |
| Narender S Dhallan | Director | Potomac, MD |
| Philip S Bayliss | Director | York, PA |
Other filings by this issuer (6)
More